Compare ASPN & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASPN | DCTH |
|---|---|---|
| Founded | 2001 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 429.3M | 372.5M |
| IPO Year | 2011 | 2015 |
| Metric | ASPN | DCTH |
|---|---|---|
| Price | $5.31 | $13.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $4.25 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 1.4M | 444.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 107.53 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $271,103,000.00 | N/A |
| Revenue This Year | N/A | $24.54 |
| Revenue Next Year | $50.03 | $33.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.30 | $8.12 |
| 52 Week High | $9.78 | $13.74 |
| Indicator | ASPN | DCTH |
|---|---|---|
| Relative Strength Index (RSI) | 45.09 | 59.24 |
| Support Level | $5.11 | $10.10 |
| Resistance Level | $6.61 | $13.74 |
| Average True Range (ATR) | 0.32 | 0.52 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 19.42 | 61.25 |
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.